The FDA has granted quick monitor designation to the prostate-specific membrane antigen (PSMA)–focused radiopharmaceutical 225Ac-FL-020 for the therapy of sufferers with metastatic castration-resistant...
The ELEVATE trial (NCT05563220) is an ongoing part 1b/2 examine investigating elacestrant (Oserdu) mixed with numerous focused therapies for sufferers with endocrine rececptor-positive...
Connell McShane and Katie Smith
3 months in the past
(NewsNation) — Catherine, Princess of Wales introduced Friday that she is within the early phases...
